weight

Starting Mounjaro? Learn the common side effects you may experience week by week, how long they last, practical tips to reduce nausea and digestive symptoms, and when to seek medical advice.

Retatrutide is an investigational triple receptor agonist that targets GLP-1, GIP, and glucagon receptors for weight management and metabolic health. Learn how it works, the latest research, and why it is not yet approved in Malaysia.

Confused about the difference between GLP-1 and GIP for weight loss? Learn how these hormones work, compare medications like Wegovy®, Ozempic®, and Mounjaro®, and discover which medical weight loss treatment may be suitable for your health goals.

Dieting alone may not be enough for sustainable weight loss. In Malaysia, medical weight loss treatments are becoming increasingly popular for targeting stubborn fat and metabolic issues. Learn the differences, benefits, and which option is right for you.

Struggling to lose weight despite dieting and exercise? You’re not alone. Many Malaysians face hidden causes like hormonal imbalance, insulin resistance, and slow metabolism. Discover why weight loss can be difficult—and what medical treatments can help you finally see results.

Mounjaro (Tirzepatide GLP-1 Agonist) is the latest innovative dual-action injectable treatment primarily used for treating type 2 diabetes and has also shown strong secondary effectiveness in weight loss.